Please reach us at if you cannot find an answer to your question.
Forward Focused is the operator-led company behind Nutrition Revolution, a first-to-market, doctor-formulated platform designed to tackle hypertension through targeted supplements, daily coaching, and behavioral habit design.
We bring 20+ years of experience scaling health and wellness companies with systems that prioritize outcomes, customer retention, and operational discipline.
Nutrition Revolution is a scalable, clinically grounded system for daily hypertension prevention.
We combine FDA-registered supplements, behavior-change coaching (Nutrivise™), and our proprietary Human OS™ "MyCardio" platform to deliver real, measurable support, far beyond what traditional supplements or care models provide.
We're targeting a $61B U.S. hypertension market, serving over 120M adults. Our initial SOM is $211M, starting in Oklahoma with a proven provider and DTC model. Long-term, we aim to scale nationally across wellness, primary care, and payer channels.
We've completed product development, clinical formulation, and platform design with top-tier functional medicine collaborators. Demand is validated through affiliate interest, early sign-ups, and category data. Now we're raising to launch at scale.
Yes. Our capital ask is based on a fully costed, lean launch model. We’ve mapped out inventory, marketing, tech development, and operational needs — and validated every line item against historical benchmarks from comparable health and wellness launches.
We’re raising the minimum required to prove traction, generate revenue within 12 months, and de-risk follow-on capital.
Yes. We’ve modeled multiple exit scenarios based on current comps in the wellness, supplement, and digital health sectors.
Comparable companies with supplement-only models have exited at 3–6x revenue, while platforms combining products and tech (like HUM Nutrition, Noom, and VitalDose) have achieved 8–12x multiples.
With our integrated approach, defensible brand, and capital-efficient growth strategy, we believe Nutrition Revolution is positioned to follow a similar path — with potential 5-year valuations exceeding $50M–$70M+ based on forecasted performance.
Yes. Our 5-year forecast is grounded in historical data from comparable supplement and wellness platform launches, combined with conservative customer acquisition and retention assumptions.
We’ve reverse-engineered our revenue targets based on known CAC, LTV, and conversion benchmarks and validated them against affiliate-driven, DTC, and B2B models used by successful wellness brands.
We’ve also built a capital efficiency model to ensure breakeven by Year 1 and scalable growth through Year 5, with multiple exit pathways modeled accordingly.
Nutrition Revolution is the first doctor-formulated platform designed to tackle hypertension with a fully integrated system — supplements, daily behavioral coaching, and a personalized health OS.
Unlike typical supplement brands, we’re not selling pills — we’re building a preventative care model that delivers daily engagement, drives long-term outcomes, and scales across DTC, B2B, and payer channels.
Our proprietary frameworks (EASE™, Metabolic OS™, and Human OS™), clinical credibility, and capital-efficient execution model give us a unique edge — with no direct competitors offering this combination in the $61B hypertension market.
No. Our sole focus is building and scaling Nutrition Revolution as a category-defining wellness platform.
While we’re open to strategic partnerships, distribution alliances, or future product integrations, we are not actively pursuing acquisitions at this time.
We’re launching direct-to-consumer with a national footprint and expanding through:
Yes. We’re actively raising capital to launch Nutrition Revolution, a doctor-formulated, behavior-driven platform designed to scale hypertension prevention across the U.S.
We’re seeking strategic investors who believe in long-term health outcomes, capital-efficient growth, and building a new standard for wellness.
Not yet, but we’re almost there.
We have spent 7 years, and have now completed product development, clinical formulation, and platform design. Our launch inventory and first production run are ready to move once funding is secured.
We’ll begin selling direct-to-consumer and through key partners as soon as we complete our seed raise and will offer early access to beta testers and subscribers.
MyCardio™ is your personalized hypertension support system — built into the Human OS™ platform.
It’s designed to help users build healthy habits, track their progress, and improve blood pressure through daily engagement and behavior change.
Key Features of MyCardio include, but not limited to;
Email: jeremy@fwd-focused.com
Call : (405) 920-8473
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.